On this page
Ledipasvir
Active ingredient 3 prescription 3 with labelling
Overview
Source: NDC DirectoryIngredient name
LEDIPASVIR
Base moiety
LEDIPASVIR
RxNorm CUI
UNII
013TE6E4WV
Medication products
6
Brand names
2
Dosage forms
3
FAERS reports
52,335 · not a risk measure
- ledipasvir Powder
- Ledipasvir and Sofosbuvir Tablet, Film Coated
- Ledipasvir SDD 50% w/w Powder
- Ledispavir Powder
- Harvoni ledipasvir and sofosbuvir · Tablet, Film Coated
- Harvoni ledipasvir and sofosbuvir · Pellet
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 3 | ledipasvir, Ledipasvir SDD 50% w/w, Ledispavir |
| TABLET, Film Coated | 2 | Ledipasvir and Sofosbuvir, Harvoni |
| Pellet | 1 | Harvoni |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |